- 5
- Bottle/Bottles
- 1INR
- Ibrutinib
- Capsules
- Blood cancer (Chronic myeloid leukaemia)
- 150mg
Ibrunat - Ibrutinib is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy or with 17p deletion.
How ibrutinib works
Ibrutinib is a Bruton's tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Specification
Packaging Size | 1 x 30 capsules |
Brand | IBRUNAT |
Composition | Ibrutinib |
Type Of Cancer | Blood Cancer |
Manufacturer | Natco |
Treatment | mantle cell lymphoma,chronic lymphocytic leukemia/small lymphocytic lymphoma |
Prescription/Non prescription | Prescription |
Dose Strength | 140mg |
Category | mantle cell lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma |
Drug | Ibrutinib |
Generic Name | Ibrutinib |
Portion A, First Floor, Old No. 131, New No. 50, Pedariyar Koil Street, Seven Wells Chennai Tamil Nadu India +918045478353
Phone :+918045478353